Teva
The curse of being Israel's most valuable company
Tower's share price has jumped nearly 900% in the past five years, but less than 24 hours after reaching the top, the world's chip stocks plummeted, and Tower's share price tumbled 10.79%
Mega deal: Teva acquires Emalex for approximately $900 million
IATI CEOs Forum meets in Kiryat Gat to discuss multinational industry resilience
Teva honored for gender equality as women reach 43% of senior management in Israel
Pfizer, AstraZeneca help launch 'computational science' lab in Israel
A partnership between six leading tech and pharma companies wants to create and adopt new AI technologies that could transform the process of drug discovery and development.
Moderna’s outgoing Israeli chief medical officer joins TEVA board
Dr. Tal Zaks will serve on the Teva board's science and technology committee.
Israel's Teva in talks to co-produce COVID-19 vaccines
Teva, the world's largest generics drugmaker, both approached and was approached by vaccine makers.
Meet the hospital staff's children joining the fight against coronavirus
The children have been developing their projects as part of the "Biotech - Next Generation" project.
Teva collaborates with Technion in fields of cancer, neurobiology
Teva has already initiated collaborations with leading academic institutions, including Tel Aviv University, the Weizmann Institute of Science, and more.
Israeli researchers provide evidence microdosing cannabis relieves pain
The researchers published their findings in the European Journal of Pain, providing the first scientific evidence that microdosing can be applied medical cannabis solution.
Teva Israel sues Abbott over baby formula
Teva is claiming that Abbott Israel, a local entity which imports Similac, is behind a “mendacious and covert slur campaign” on social media.
Teva Naot opens fourth branch in Japan
Teva Naot markets about 100 different models of Japanese women’s fashion shoes.
Florida has not distributed most of hydroxychloroquine doses from Israel
Only a handful of hospitals have requested access to the hydroxychloroquine stockpile, according to the report.
Teva gets approval in China for Huntington's disease treatment
Teva’s CEO Kare Schultz said the drug would be priced somewhat lower in China than in the United States.
